日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional drug screening of tumor organoids on an active-matrix digital microfluidic chip for cancer precision medicine.

在活性基质数字微流控芯片上对肿瘤类器官进行功能性药物筛选,用于癌症精准医疗。

Sun Ruimeng, Feng Zhengyang, Wu Tong, Ding Fangqiu, Wu Yong, Jin Kai, Li Li, Jia Zhiqiang, Gao Ruoqian, Cong Yingge, Ho Tsung-Yi, Ma Hanbin, Hu Siyi, Zhang Lixing, Dong Wenfei

Synergistic Mechanisms and Product Regulation in the Co-Pyrolysis of Biomass and Food Packaging Waste: A Study Based on Reaction Kinetics and GHG Calculation

生物质与食品包装废弃物共热解的协同机制及产物调控:基于反应动力学和温室气体计算的研究

Li, Gang; Lai, Xingyang; Gong, Jue; Zhang, Tong; Xu, Ke; Feng, Zhengyang; Yao, Xiaolong

The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation

SLC16A4在肝细胞癌中的多维作用:计算机模拟分析——预后意义、代谢通路和免疫微环境调控

Jiang, Lili; Shen, Yi; Feng, Zhengyang; Wang, Yong; Zhu, Yaqun; Shen, Yuntian; Peng, Qiliang

MicroRNA-486: a dual-function biomarker for diagnosis and tumor immune microenvironment characterization in non-small cell lung cancer

MicroRNA-486:一种用于非小细胞肺癌诊断和肿瘤免疫微环境表征的双功能生物标志物

Yu, Jun; Shen, Yi; Xu, Yao; Feng, Zhengyang; Shen, Yuntian; Zhu, Yaqun; Huan, Jian; Peng, Qiliang

Association of metabolic dysregulation with treatment response in rectal cancer patients undergoing chemoradiotherapy

代谢紊乱与接受放化疗的直肠癌患者的治疗反应之间的关联

Peng, Qiliang; Shen, Yi; Xu, Yingying; Feng, Zhengyang; Xu, Yao; Wang, Yong; Zou, Li; Zhu, Yaqun; Shen, Yuntian

Identification of a novel immune-related gene signature by single-cell and bulk sequencing for the prediction of the immune landscape and prognosis of breast cancer

利用单细胞和批量测序鉴定一种新的免疫相关基因特征,用于预测乳腺癌的免疫图谱和预后

Gu, Yanlin; Feng, Zhengyang; Xu, Xiaoyan; Jin, Liyan

LINC01929 Is a Prognostic Biomarker for Multiple Tumours and Promotes Cell Proliferation in Breast Cancer Through the TNF/STAT3 Axis

LINC01929 是一种多种肿瘤的预后生物标志物,并通过 TNF/STAT3 轴促进乳腺癌细胞增殖。

Gu, Yanlin; Feng, Zhengyang; Xu, Xiaoyan; Jin, Liyan; Jiang, Guoqin

Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patients

血液脂质代谢生物标志物正逐渐成为癌症患者生存的重要预后指标。

Peng, Qiliang; Zhan, Changli; Shen, Yi; Xu, Yao; Ren, Bixin; Feng, Zhengyang; Wang, Yong; Zhu, Yaqun; Shen, Yuntian

Development and validation of a prognostic risk score model for hepatocellular carcinoma in the Asian population based on immunogenic cell death-related genes

基于免疫原性细胞死亡相关基因,构建并验证亚洲人群肝细胞癌预后风险评分模型

Feng, Zhengyang; Wang, Yanjie; Liang, Yong; Gu, Xuhao; Yang, Yinyin; Zhang, Yusong; Peng, Qiliang

Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study

吉西他滨联合雷替曲塞或S-1与标准三线疗法治疗转移性结直肠癌的疗效和安全性:一项回顾性队列研究

Tao, Jialong; Zhang, Yingtian; Wang, Yanjie; Huang, Sijia; Gao, Wenwen; Dai, Liya; Feng, Zhengyang; Jiao, Chenchen; Zhang, Yusong